Press Release

Akumin Inc. Announces Final Results of Exchange Offer

News Provided by Akumin Inc / Feb 19, 2026. 9:00am ET

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, EXCEPT TO “QUALIFIED INSTITUTIONAL BUYERS” (“QIBs”) IN RELIANCE ON RULE 144A (“RULE 144A”) UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR IN OR INTO ANY OTHER JURISDICTION IF SUCH AN ACTION IS PROHIBITED BY APPLICABLE LAW.

Plantation, FL – February 19, 2026 – Akumin Inc. (“Akumin”) announced today that, as of the Expiration Time, being 5:00 p.m., New York City time, on February 18, 2026, holders of $436,222,000 in aggregate principal amount of 2027 Notes (accounting for 100.00% of the outstanding 2027 Notes) and holders of $354,483,000 in aggregate principal amount of 2028 Notes (accounting for 99.97% of the outstanding 2028 Notes) have validly tendered their Old Notes in the Exchange Offer. Capitalized terms used but not defined in this announcement have the meaning given to them in the announcements made by Akumin on January 20, 2026 and February 3, 2026.

For each $1.00 principal amount of Old Notes validly tendered and accepted at or before the Expiration Time, all tendering Eligible Holders are entitled to receive the Total Exchange Consideration, being $1.00 principal amount of New Notes, and will still receive, in cash, accrued and unpaid interest on such Old Notes from and including the last interest payment date on such Old Notes prior to the Settlement Date, to, but not including the Settlement Date. Payment of the Total Exchange Consideration will occur on the Settlement Date, which is expected to be February 23, 2026, or as soon as practicable thereafter. Akumin reserves the right to extend the Settlement Date, in its discretion, subject to applicable securities law and the terms of the previously announced Support Agreement (as defined in the Offer to Exchange) entered into by Akumin and certain noteholders.

As previously announced, the requisite consents were received to adopt the Proposed Amendments. Pursuant to Section 9.02 of each Old Notes Indenture, Akumin hereby notifies holders of the Old Notes that it has entered into a Supplemental Indenture in respect of each series of the Old Notes relating to the Proposed Amendments.

The New Notes have not been and will not be registered under the Securities Act or any other securities laws. Accordingly, the New Notes will be subject to restrictions on transferability and resale and may not be transferred or resold except as permitted under the Securities Act and other applicable securities laws, pursuant to registration or exemption therefrom. Investors should be aware that they may be required to bear the financial risks of this investment for an indefinite period of time.

Kroll Issuer Services (US) is acting as the Exchange and Information Agent in connection with the Exchange Offer and Consent Solicitation. Sidley Austin LLP is acting as legal counsel to Akumin in connection with the Exchange Offer and Consent Solicitation. Akin Gump Strauss Hauer & Feld LLP is acting as counsel to certain Supporting Holders in connection with the Exchange Offer and Consent Solicitation.

About Akumin

Akumin is a leading U.S. provider of advanced imaging and radiation oncology services, committed to excellence in patient care and expanding access to life-saving diagnostics and treatments. Serving millions annually, Akumin operates one of the nation’s largest networks of fixed-site radiology centers and mobile imaging and oncology solutions, including the innovative Akumin AXIS Expandable Patient Solutions®. Partnering with over 800 hospitals and physician groups, Akumin combines clinical expertise, operational excellence, and advanced technology to broaden access, enhance care standards, and meet community needs. Through innovation and collaboration, Akumin is pioneering the future of patient-centered care. For more information, visit www.akumin.com.

Forward-Looking Statements

Certain information in this press release constitutes forward‐looking information. In some cases, but not necessarily in all cases, forward‐looking information can be identified by the use of forward‐looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved.” In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward‐looking information. Statements containing forward‐looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events.

Forward‐looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Akumin as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward‐looking information. Factors that could cause actual results to differ materially from such forward‐looking information include, but are not limited to, competitive and general economic conditions domestically and internationally; acts of terrorism, war, governmental action, natural disasters, pandemics and other force majeure events; cyberattacks; changes in the legal and regulatory environment; changes in customer demand and the other risks and contingencies detailed in the Offer to Exchange. Akumin therefore cautions readers against relying on such forward-looking statements.

All forward‐looking statements attributable to the Akumin or persons acting on Akumin’s behalf are expressly qualified in their entirety by the foregoing cautionary statements. These factors are not intended to represent a complete list of the factors that could affect Akumin; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward‐looking statements contained in this press release are made as of the date of this press release, and Akumin expressly disclaims any obligation to update or alter statements containing any forward‐looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

No Offer or Solicitation

This communication is not intended to and does not constitute an offer to sell or purchase, or the solicitation of an offer to sell or purchase, or the solicitation of tenders or consents with respect to any security. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Exchange Offer and Consent Solicitation are being made solely pursuant to the Offer to Exchange and only to such persons and in such jurisdictions as is permitted under applicable law.

Contact

Akumin Investor Relations
investorrelations@akumin.com